| Dr Cameron Douglas, DO | |
|
80 Highland St, Laconia, NH 03246-3235 | |
| (603) 524-3211 | |
| (603) 527-2984 |
| Full Name | Dr Cameron Douglas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 80 Highland St, Laconia, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164080354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5151013718 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 24122 (New Hampshire) | Primary |
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.
Some employers are exploiting the vulnerability of young unsupported workers, sacking them in unfair circumstances, a new study by Queensland University of Technology (QUT) has found.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011. Thousands of residents were affected. A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December 2010, by Premier of Queensland, Anna Bligh. DSM recognizes the efforts of Queenslanders who pitched in to help their fellow citizens clean-up in the wake of the floods and help families in need, many of whom lost everything.
› Verified 3 days ago
| Entity Name | Concord Hospital-laconia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053993741 PECOS PAC ID: 7012326259 Enrollment ID: O20210429001355 |
News Archive
Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.
Some employers are exploiting the vulnerability of young unsupported workers, sacking them in unfair circumstances, a new study by Queensland University of Technology (QUT) has found.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011. Thousands of residents were affected. A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December 2010, by Premier of Queensland, Anna Bligh. DSM recognizes the efforts of Queenslanders who pitched in to help their fellow citizens clean-up in the wake of the floods and help families in need, many of whom lost everything.
› Verified 3 days ago
| Entity Name | Concord Hospital - Franklin |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1700960895 PECOS PAC ID: 4183033293 Enrollment ID: O20210504000723 |
News Archive
Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.
Some employers are exploiting the vulnerability of young unsupported workers, sacking them in unfair circumstances, a new study by Queensland University of Technology (QUT) has found.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011. Thousands of residents were affected. A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December 2010, by Premier of Queensland, Anna Bligh. DSM recognizes the efforts of Queenslanders who pitched in to help their fellow citizens clean-up in the wake of the floods and help families in need, many of whom lost everything.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cameron Douglas, DO 80 Highland St, Laconia, NH 03246-3235 Ph: (603) 524-3211 | Dr Cameron Douglas, DO 80 Highland St, Laconia, NH 03246-3235 Ph: (603) 524-3211 |
News Archive
Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.
Some employers are exploiting the vulnerability of young unsupported workers, sacking them in unfair circumstances, a new study by Queensland University of Technology (QUT) has found.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
Significant flooding occurred in many areas of Queensland during late December 2010 and early January 2011. Thousands of residents were affected. A disaster relief appeal, the 'Premier's Disaster Relief Appeal', was launched on 29 December 2010, by Premier of Queensland, Anna Bligh. DSM recognizes the efforts of Queenslanders who pitched in to help their fellow citizens clean-up in the wake of the floods and help families in need, many of whom lost everything.
› Verified 3 days ago
Dr. Nicolette Alexandria Metrusias, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-2977 | |
Dr. Marie Ann Arringdale, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Thomas B Scott, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-2819 Fax: 603-527-2984 | |
Dr. Sandra L Maruszak, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 80 Highland Street, Lakes Region General Hospital, Laconia, NH 03246 Phone: 603-527-2819 Fax: 603-527-2984 | |
Dr. Rudolph Andrew Cartier Iii, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Brian J Jeffery, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-2819 Fax: 603-527-2984 |